Learn more

THROMBOGENICS NV

Overview
  • Total Patents
    100
  • GoodIP Patent Rank
    172,425
  • Filing trend
    ⇩ 100.0%
About

THROMBOGENICS NV has a total of 100 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are SHIRE PHARMACEUTICALS IRELAND LTD, ZYMENEX AS and SWEDISH ORPHAN BIOVITRUM AB PUBL.

Patent filings per year

Chart showing THROMBOGENICS NVs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zwaal Richard Reinier 29
#2 Pakola Steve 17
#3 De Smet Marc 16
#4 Ngo Hoa Thu 13
#5 Zwaal Richard 13
#6 Fromond Claudia 12
#7 Stassen Jean-Marie 12
#8 Collen Desire 11
#9 Notebaert Sofie 11
#10 Carmeliet Peter 9

Latest patents

Publication Filing date Title
IL235188D0 Anti-pdgf-c antibodies
NZ724395A Anti-pdgf-c antibodies
AU2013205649A1 Improving trabeculectomy outcome
WO2013139956A1 Antibodies abrogating cell binding to lactadherin
CN103764163A Plasminogen and plasmin variants
CN103384722A Plasminogen and plasmin variants
EP2480249A1 Plasmin for the treatment of filtration failure after trabeculectomy
BR112012000650A2 "plasminogen and plasmin variants"
NZ597452A Variants of plasminogen and plasmin
CN101848928A Staphylokinase variant
EP2009026A1 Anti-VPAC1 antibodies and their uses
AU2004264265A1 Antibodies against factor VIII with modified glycosylation in the variable region